###begin article-title 0
###xml 87 91 <span type="species:ncbi:10090">Mice</span>
Pathogenic Roles of CD14, Galectin-3, and OX40 during Experimental Cerebral Malaria in Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: MSO LA SK. Performed the experiments: MSO VM BM NG VA JMW LJF HZ MT. Analyzed the data: MSO VM BM NG VA JMW LJF TFM HZ MT JAB LA SK. Contributed reagents/materials/analysis tools: TFM JAB SK. Wrote the paper: MSO LA SK.
###end p 1
###begin p 2
###xml 313 331 313 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium berghei</italic>
###xml 1493 1503 1493 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1628 1629 1628 1629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1634 1635 1634 1635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1666 1669 1666 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Nitcheu1">[1]</xref>
###xml 1818 1819 1818 1819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1827 1828 1827 1828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 313 331 <span type="species:ncbi:5821">Plasmodium berghei</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1024 1028 <span type="species:ncbi:10090">mice</span>
###xml 1221 1225 <span type="species:ncbi:10090">mice</span>
###xml 1318 1322 <span type="species:ncbi:10090">mice</span>
###xml 1493 1503 <span type="species:ncbi:5821">P. berghei</span>
An in-depth knowledge of the host molecules and biological pathways that contribute towards the pathogenesis of cerebral malaria would help guide the development of novel prognostics and therapeutics. Genome-wide transcriptional profiling of the brain tissue during experimental cerebral malaria (ECM ) caused by Plasmodium berghei ANKA parasites in mice, a well established surrogate of human cerebral malaria, has been useful in predicting the functional classes of genes involved and pathways altered during the course of disease. To further understand the contribution of individual genes to the pathogenesis of ECM, we examined the biological relevance of three molecules - CD14, galectin-3, and OX40 that were previously shown to be overexpressed during ECM. We find that CD14 plays a predominant role in the induction of ECM and regulation of parasite density; deletion of the CD14 gene not only prevented the onset of disease in a majority of susceptible mice (only 21% of CD14-deficient compared to 80% of wildtype mice developed ECM, p<0.0004) but also had an ameliorating effect on parasitemia (a 2 fold reduction during the cerebral phase). Furthermore, deletion of the galectin-3 gene in susceptible C57BL/6 mice resulted in partial protection from ECM (47% of galectin-3-deficient versus 93% of wildtype mice developed ECM, p<0.0073). Subsequent adherence assays suggest that galectin-3 induced pathogenesis of ECM is not mediated by the recognition and binding of galectin-3 to P. berghei ANKA parasites. A previous study of ECM has demonstrated that brain infiltrating T cells are strongly activated and are CD44+CD62L- differentiated memory T cells [1]. We find that OX40, a marker of both T cell activation and memory, is selectively upregulated in the brain during ECM and its distribution among CD4+ and CD8+ T cells accumulated in the brain vasculature is approximately equal.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 58 79 58 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum</italic>
###xml 464 477 464 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 488 491 488 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Taylor1">[2]</xref>
###xml 58 79 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 210 218 <span type="species:ncbi:9606">children</span>
###xml 464 477 <span type="species:ncbi:5833">P. falciparum</span>
Cerebral malaria (CM) is the most severe consequence of a Plasmodium falciparum infection and along with severe anemia is a major pathogenic factor behind the approximately 1 million deaths per year, mostly in children aged 2-5 years living in sub-Saharan Africa. In endemic areas, CM has been described as presence of a set of well-defined clinical features with the primary characteristics of unarousable coma, exclusion of encephalopathies, and confirmation of P. falciparum infection [2].
###end p 4
###begin p 5
###xml 160 170 160 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 160 170 <span type="species:ncbi:5821">P. berghei</span>
###xml 176 182 <span type="species:ncbi:10090">murine</span>
###xml 261 266 <span type="species:ncbi:9606">human</span>
###xml 279 285 <span type="species:ncbi:10090">murine</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 576 581 <span type="species:ncbi:9606">human</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
A substantial amount of our knowledge regarding the underlying molecular mechanisms that contribute towards the pathogenesis of CM comes from studies using the P. berghei ANKA murine model of experimental cerebral malaria (ECM), a well-established surrogate of human CM. In this murine model, depending on the host genetic background, mice can be broadly categorized as susceptible or resistant to ECM. Although infection results in eventual death of all mice, the majority of susceptible mice develop neurological symptoms between days 6-10 post-infection that closely mimic human CM. In contrast, resistant mice (as well as a small portion of susceptible mice) do not exhibit clinical or pathological symptoms of ECM during this 6-10 day window of infection but instead succumb to hyperparasitemia and severe anemia between days 15-21 post-infection.
###end p 5
###begin p 6
###xml 236 239 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Berendt1">[3]</xref>
###xml 325 328 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Clark1">[4]</xref>
###xml 381 382 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 456 459 452 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Maegraith1">[5]</xref>
###xml 461 464 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Potter1">[6]</xref>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
Several decades of experimental evidence suggest that the clinical manifestations of ECM result from immuno-pathological events that include: 1) the sequestration of mature form parasites in brain capillaries (sequestration hypothesis) [3]; 2) overexpression of inflammatory mediators such as TNF-alpha (cytokine hypothesis) [4]; and 3) disruption of the blood brain barrier by CD8+ T cell mediated apoptosis of endothelial cells (permeability hypothesis) [5], [6]. Recent studies performed in gene deficient mice have confirmed that this complex polygenic trait is influenced by the participation of a growing number of functionally diverse host factors.
###end p 6
###begin p 7
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 182 185 182 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Finley1">[7]</xref>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 373 376 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Grau1">[8]</xref>
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Yanez1">[9]</xref>
###xml 399 400 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Belnoue1">[10]</xref>
###xml 650 653 650 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Nitcheu1">[1]</xref>
###xml 117 126 <span type="species:ncbi:10090">nude mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
T cells play a critical role in the pathogenesis of ECM. This was first recognized when it was reported that athymic nude mice do not develop symptoms of ECM during a Pb-A infection [7]. Subsequently, studies based on depletion of T cell subsets in mice and in CD4- and CD8-deficient mice established that both CD4+ and CD8+ T cells are required for the development of ECM [8], [9]. Importantly, CD4+ T cells are critical for the induction of ECM, whereas CD8+ T cells are critical during the effector phase of ECM [10]. Accumulating evidence suggests that brain infiltrating T cells during ECM are strongly activated and differentiated memory cells [1].
###end p 7
###begin p 8
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Oakley1">[11]</xref>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
Previously, we utilized a host genome-wide approach to identify specific alterations in transcription levels by microarray of host genes in mice in the moribund state. After accounting for confounding factors such as mouse genetic background, parasite burden, and disease state (e.g., moribund vs. non-moribund and susceptibility vs. resistance to ECM), we found that more than 200 host genes, based on their transcriptional alterations, were associated with the pathogenic events occurring during ECM [11]. Next we wanted to determine which of the transcriptional altered genes in our dataset were directly involved in the pathogenesis of ECM. The initial criterion for the selection of molecules for further studies was based on functional properties (e.g. cytoadherence, immunological, and inflammatory, etc.) that may suggest a role in the pathogenesis of ECM. These functional properties were ascertained based on earlier published studies and by extensive bioinformatics analyses. Using these criteria, we chose to examine the biological relevance of three molecules - CD14, galectin-3, and OX40 in our dataset that we predicted, based on their function, may play a direct role in the pathogenesis of ECM.
###end p 8
###begin p 9
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Wright1">[12]</xref>
###xml 541 545 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Devitt1">[13]</xref>
###xml 678 681 671 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Potter1">[6]</xref>
###xml 683 687 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Wiese1">[14]</xref>
###xml 689 693 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Wiese2">[15]</xref>
CD14 is a leucine-rich-repeat (LRR) surface protein related to the extracellular LRR-portion of the TLR proteins. It has two well characterized functions that may be pertinent to the pathogenesis of ECM: 1) it is a receptor for lipopolysaccharide of Gram negative bacteria [12] and recognition of microbial ligands by host CD14 often results in the activation of a potent inflammatory cascade, including the release of TNF-alpha and IL-1beta. 2) CD14 is a major receptor involved in the nonphlogistic clearance of cells undergoing apoptosis [13] and its overexpression in the brain may reflect the well-documented increase in endothelial and neuronal apoptotic cells during ECM [6], [14], [15].
###end p 9
###begin p 10
###xml 373 377 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Barondes1">[16]</xref>
###xml 379 383 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Rabinovich1">[17]</xref>
###xml 483 487 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Moutsatsos1">[18]</xref>
###xml 489 493 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Hughes1">[19]</xref>
###xml 731 735 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Rabinovich1">[17]</xref>
###xml 737 741 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Almkvist1">[20]</xref>
###xml 753 757 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-NangiaMakker1">[21]</xref>
###xml 759 763 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Nakahara1">[22]</xref>
###xml 776 780 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Liu1">[23]</xref>
###xml 800 804 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Hughes2">[24]</xref>
###xml 1059 1063 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Sato1">[25]</xref>
###xml 1181 1198 1178 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma cruzi</italic>
###xml 1198 1202 1195 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Kleshchenko1">[26]</xref>
###xml 1204 1223 1201 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schistosoma mansoni</italic>
###xml 1223 1227 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-vandenBerg1">[27]</xref>
###xml 1229 1246 1226 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Toxoplasma gondii</italic>
###xml 1246 1250 1243 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Bernardes1">[28]</xref>
###xml 1256 1272 1253 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania major</italic>
###xml 1272 1276 1269 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Pelletier1">[29]</xref>
###xml 1181 1198 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
###xml 1204 1223 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 1229 1246 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 1256 1272 <span type="species:ncbi:5664">Leishmania major</span>
Galectin-3 belongs to a large family of animal lectins defined by an evolutionary conserved carbohydrate-recognition-binding domain (CRD), which recognizes beta-galactosides. Galectin-3 has a preference for larger oligosaccharides, such as polyNAc-lactosaminoglycan, a polymer of beta (1,3)-linked LacNAc units found on many extracellular matrix and cell surface molecules [16], [17]. Galectin-3 lacks conventional signal peptides and has been localized to the nucleus and cytoplasm [18], [19]. However, it is also secreted by a non-classical pathway and is found on cell surfaces as well as the extracellular matrix. A wide array of functions has previously been assigned to this molecule including the regulation of inflammation [17], [20], apoptosis [21], [22], chemotaxis [23], and cell adhesion [24]. However, given that its preferred target is predominantly extracellular rather than intracellular proteins, it is likely to have a role in interacting with endogenous extracellular glycoproteins or foreign pathogen associated molecular patterns (PAMPs) [25]. Because of these observations and previous reports that galectin-3 can significantly alter the pathogenic course of Trypanosoma cruzi[26], Schistosoma mansoni[27], Toxoplasma gondii[28], and Leishmania major[29] protozoan infections, we selected this molecule for further examination of a functional role during ECM.
###end p 10
###begin p 11
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 81 84 81 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Finley1">[7]</xref>
###xml 85 88 85 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Yanez1">[9]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Mallett1">[30]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Hori1">[31]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Weinberg1">[32]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-SalekArdakani1">[33]</xref>
###xml 519 520 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 528 529 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 607 610 607 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Nitcheu1">[1]</xref>
CD4+ and CD8+ T cells have been shown to be necessary for the development of ECM [7]-[9]. Therefore, we also investigated the role of the costimulatory molecule OX40 during ECM. OX40, a member of the tumor necrosis factor receptor superfamily [30], is expressed primarily on activated T cells [31] and has been shown to play an important role in the generation of memory [32], [33]. We were particularly interested in measuring the proportion of T cells expressing OX40 because a large portion of brain infiltrating CD4+ and CD8+ T cells have been shown to be differentiated memory T lymphocytes during ECM [1].
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 201 208 201 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 209 215 <span type="species:ncbi:10090">murine</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
Infection with Pb-A parasites is fatal in 100% of mice. However, the cause of death may vary from ECM to hyperparasitemia and severe anemia depending on the host genetic background. In this study, all in vivo murine experiments were performed on the C57BL/6 background, where in our hands, 80-100% of wildtype (WT) mice develop symptoms of ECM.
###end p 13
###begin title 14
###xml 8 12 <span type="species:ncbi:10090">mice</span>
CD14-KO mice are protected against ECM and protection is parasitemia dependent
###end title 14
###begin p 15
###xml 79 92 79 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Wenisch1">[34]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Oakley1">[11]</xref>
###xml 512 519 512 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 788 792 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 847 849 847 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</italic>
###xml 842 849 842 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g001">Fig. <italic>1A</italic></xref>
###xml 79 92 <span type="species:ncbi:5833">P. falciparum</span>
###xml 104 110 <span type="species:ncbi:9606">humans</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
A correlation between elevated levels of soluble CD14 in serum and complicated P. falciparum malaria in humans has previously been reported [34]. In addition, overexpression of CD14 transcription in brain tissue of susceptible mice exhibiting symptoms of ECM has recently been described by our group [11]. To delineate a biological role for CD14 in the pathogenesis of ECM, we measured the susceptibility of CD14-KO mice to ECM. Simultaneously, we also determined if absence of host CD14 had an influence on the in vivo growth of intra-erythrocytic parasites which may in turn influence susceptibility to ECM. In cumulative data collected from two independent experiments (n = 10 per group for experiment 1 and 9 CD14-KO and 10 WT for experiment 2), we find that following infection with Pb-A parasites, 16 of 20 (80%) WT mice developed ECM (Fig. 1A) by day 8. In comparison, only 4 of 19 (21%) CD14-KO mice developed symptoms of ECM indicating that loss of CD14 confers a highly significant protection from ECM (p<0.0004, Fisher's exact test). These results strongly indicate that CD14 plays an important role in the expression of ECM. Although protection in CD14-KO mice was highly significant, this protection was incomplete, suggesting that additional host molecules with functionally redundant roles may be able to substitute for CD14 in the pathogenesis of ECM.
###end p 15
###begin title 16
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Deletion of CD14 confers protection against ECM and has a negative effect on parasite growth in vivo.
###end title 16
###begin p 17
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 197 199 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</italic>
###xml 300 302 300 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 485 487 485 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
C57BL/6 WT and CD14-KO mice were challenged with 106Pb-A parasites and susceptibility to ECM was determined based on symptoms exhibited and ability of mice to survive beyond day 10 post-infection. A: 16 of 20 (80%) WT mice versus 4 of 19 (21%) CD14-KO mice succumbed to ECM by day 10 post-challenge. B: CD14-KO mice that did not develop ECM had approximately 2-fold lower parasite burden between days 6 to 8 and 3.6-fold lower parasite burden between days 9 to 13 post-Pb-A infection. C: In contrast, WT and CD14-KO mice that developed ECM had no significant differences in parasite burden at onset of ECM.
###end p 17
###begin p 18
###xml 321 323 321 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1B</italic>
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g001">Fig. <italic>1B</italic></xref>
###xml 704 706 700 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1C</italic>
###xml 699 706 695 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g001">Fig. <italic>1C</italic></xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1094 1098 <span type="species:ncbi:10090">mice</span>
Surprisingly, we also find that loss of CD14 had an adverse effect on parasite growth in C57BL/6 mice (p<0.0001, two-way ANOVA). Among mice that did not develop ECM, between days 6 to 8 post-infection, mean parasite burden was approximately 2-fold lower in CD14-KO mice compared to WT mice (4.2% vs. 8.3% on day 6) (Fig. 1B). The difference in parasitemia was even more drastic (3.6-fold lower) between days 9 (4.6% vs. 16.9%) and 13 (12.2% vs. 43.6%), the post-ECM phase. However, among mice that developed ECM, there was no significant difference in mean parasitemia between WT (8.1+/-.6% on day 6) and CD14-KO (8.3+/-2.2% on day 6) mice during the cerebral phase (p = 0.9185, Mann-Whitney test) (Fig. 1C). Although it is possible that the dual roles of CD14 as a mediator of the pathogenesis of ECM and a positive regulator of parasite density operate independent of each other, our results suggest that CD14-mediated pathogenesis of ECM is directly dependent on the level of parasitemia; CD14-KO mice that were able to overcome resistance to ECM (n = 4) had a parasite burden similar to WT mice.
###end p 18
###begin title 19
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lgals3</italic>
Deletion of the lgals3 gene results in partial protection from ECM
###end title 19
###begin p 20
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Oakley1">[11]</xref>
###xml 924 925 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 919 925 911 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g002">Fig. <italic>2</italic></xref>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
We previously reported that transcription of galectin-3 is induced in brain tissue of susceptible mice that develop ECM and compared to CD8-KO mice which are resistant to ECM, galectin-3 was overexpressed by 6.8 fold in moribund mice [11]. In this study, we quantified the amount of galectin-3 protein in brain tissue of mice during the cerebral phase in order to establish whether galectin-3 expression in the brain is a reliable biomarker of the clinical state of ECM. In an ECL-based, semi-quantitative western blot assay, galectin-3 protein expression (represented in average integrated optical densities [IOD] units) was significantly higher in moribund (9,620+/-1,058) than in non-moribund (1,620+/-381), CD8-KO (2,200+/-265) and normal mice (900+/-208). Thus, compared to non-moribund and resistant CD8-KO mice, moribund mice exhibited a 5.9 and 4.4 fold increase, respectively in galectin-3 protein expression (Fig. 2).
###end p 20
###begin title 21
Induction of galectin-3 during experimental cerebral malaria.
###end title 21
###begin p 22
###xml 501 522 501 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
Expression of galectin-3 was measured in brain tissue samples in individual moribund (n = 5), non-moribund (n = 5), CD8-KO ( = 3), and normal (non-infected, n = 3) C57BL/6 mice by ECL-based western blot analysis. Expression levels were determined based on the intensity of protein bands using Meta1 Morph 6.1 software and are represented as average integrated optical densities (IOD) units. The IOD units shown are valuesx1000. Details of antibodies and western blot reagents used can be found in the Materials and Methods.
###end p 22
###begin p 23
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 197 199 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3A</italic>
###xml 192 199 192 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g003">Fig. <italic>3A</italic></xref>
###xml 657 659 657 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3B</italic>
###xml 652 659 652 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g003">Fig. <italic>3B</italic></xref>
###xml 973 981 971 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 983 993 981 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. mansoni</italic>
###xml 999 1007 997 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 1028 1032 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Kleshchenko1">[26]</xref>
###xml 1034 1038 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-vandenBerg1">[27]</xref>
###xml 1040 1044 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Pelletier1">[29]</xref>
###xml 1159 1163 1157 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 1310 1314 1308 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 1399 1401 1391 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4B</italic>
###xml 1394 1401 1386 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g004">Fig. <italic>4B</italic></xref>
###xml 1455 1457 1447 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</italic>
###xml 1450 1457 1442 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g004">Fig. <italic>4A</italic></xref>
###xml 1657 1659 1649 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4C</italic>
###xml 1652 1659 1644 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g004">Fig. <italic>4C</italic></xref>
###xml 1748 1750 1740 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4D</italic>
###xml 1743 1750 1735 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g004">Fig. <italic>4D</italic></xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 973 981 <span type="species:ncbi:5693">T. cruzi</span>
###xml 983 993 <span type="species:ncbi:6183">S. mansoni</span>
###xml 999 1007 <span type="species:ncbi:5664">L. major</span>
###xml 1276 1281 <span type="species:ncbi:10090">mouse</span>
###xml 1512 1517 <span type="species:ncbi:10090">mouse</span>
We next measured the susceptibility of galectin-3-KO mice to ECM following infection with Pb-A parasites. In a cumulation of two independent experiments, 14 of 15 (93%) WT mice developed ECM (Fig. 3A) by day 7 post-infection. In comparison, only 8 of 17 galectin-3-KO mice (47%) developed symptoms of ECM by day 8 post-infection, indicating that loss of galectin-3 conferred significant (p<0.0073, Fisher's exact test) protection from ECM. We also determined parasitemia beginning on day 4 post infection. Interestingly, in mice that developed ECM, parasitemia was moderately higher in galectin-3-KO mice compared to WT mice (p<0.0137, two-way ANOVA) (Fig. 3B). Similarly, among mice that did not develop ECM, although parasitemia did not differ greatly between days 4 and 12, we noted that parasitemia was markedly higher on day 20 in the galectin-3-KO (53.3+/-8.29%) versus WT (36%) group. Because previous studies have demonstrated an ability of galectin-3 to adhere to T. cruzi, S. mansoni, and L. major protozoan parasites [26], [27], [29], we investigated whether galectin-3 induced pathogenesis of ECM might be mediated by the binding of galectin-3 to Pb-A parasites. Therefore, we measured the capacity of galectin-3 to adhere to malaria parasites after incubation of mouse recombinant galectin-3 with Pb-A schizonts for 1 h at 37degreesC. We find that galectin-3 binding to parasites (Fig. 4B) was not significantly above background levels (Fig. 4A). We also noticed low levels of galectin-3 binding to mouse lymphocytes. This binding decreased slightly in the presence of sucrose, a control disaccharide that is not recognized by galectin-3 (Fig. 4C), and lactose, a competitive disaccharide that has a high affinity for galectin-3 (Fig. 4D), suggesting that the observed adherence of galectin-3 to lymphocytes may be nonspecific.
###end p 23
###begin title 24
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Galectin-3 deficient mice are partially protected against experimental cerebral malaria and developed higher peripheral parasitemia.
###end title 24
###begin p 25
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</italic>
###xml 172 174 172 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 333 335 333 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
A: Fourteen of 15 (93%) WT mice versus 8 of 17 (47%) galectin-3-KO mice succumbed to ECM by day 8 post-infection. Data shown is cumulated from two independent experiments. B: In galectin-3-KO (n = 5) and WT (n = 9) mice that developed ECM, galectin-3-KO mice had moderately higher parasitemia than WT mice (p<0.0137, two-way ANOVA). C: Among mice that did not develop ECM, although parasitemia did not differ markedly between days 4 and 12, parasitemia was higher on day 20 in the galectin-3-KO (53.3+/-8.29%, n = 4) versus WT (36%, n = 1) group.
###end p 25
###begin title 26
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
Pb-A parasites collected from whole blood at approximately 10% parasitemia were cultured overnight to obtain schizont stage parasites.
###end title 26
###begin p 27
###xml 35 37 35 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</italic>
###xml 52 54 52 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 66 68 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</italic>
###xml 96 98 96 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D:</italic>
###xml 154 158 <span type="species:ncbi:9925">goat</span>
###xml 210 216 <span type="species:ncbi:9793">donkey</span>
###xml 239 243 <span type="species:ncbi:9925">goat</span>
###xml 291 296 <span type="species:ncbi:10090">mouse</span>
Parasites were then incubated with A: no galectin-3 B: galectin-3 C: galectin-3 and sucrose and D: galectin-3 and lactose and subsequently stained with a goat antibody specific for galectin-3 and a fluorescent donkey antibody specific for goat IgG. Right panels show galectin-3 adherence to mouse lymphocytes. Images were collected on an epifluorescence microscope.
###end p 27
###begin title 28
Selective expression of OX40 during experimental cerebral malaria
###end title 28
###begin p 29
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Weinberg2">[35]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Carboni1">[36]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Higgins1">[37]</xref>
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Yoshioka1">[38]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Giacomelli1">[39]</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Oakley1">[11]</xref>
###xml 779 781 779 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5A</italic>
###xml 774 781 774 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g005">Fig. <italic>5A</italic></xref>
###xml 881 883 881 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 876 883 876 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g005">Fig. <italic>5B</italic></xref>
###xml 940 944 940 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
OX40 is a costimulatory molecule involved in T cell activation and generation of memory. OX40 has previously been implicated in the pathogenesis of several inflammatory diseases such as multiple sclerosis [35], [36], inflammatory bowel disease [37], and rheumatoid arthritis [38], [39]. In our dataset, transcription of OX40 in the brain was increased by approximately two fold in moribund mice compared to non-moribund and resistant mice [11]. We wanted to determine if OX40 protein is preferentially expressed in the brain during ECM. To accomplish this, we performed immunohistological studies in brain sections from C57BL/6 moribund and non-moribund mice. We found that mice displaying symptoms of ECM strongly expressed OX40 on a subset of lymphoid cells in the brain (Fig. 5A). In comparison, tissue sections from non-moribund mice had much fewer cells expressing OX40 (Fig. 5B) suggesting that expression of OX40 in the brain during Pb-A infection may correlate with disease progression.
###end p 29
###begin title 30
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Expression of OX40 in the brain of mice with experimental cerebral malaria.
###end title 30
###begin p 31
###xml 20 22 20 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</italic>
###xml 36 38 36 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:9925">goat</span>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
Brain sections from A: moribund and B: non-moribund Pb-A infected mice were stained with a goat antibody specific for mouse OX40 and visualized at 40xmagnification. Immunostaining demonstrated strong but highly specific staining of a subset of lymphoid cells within and adjacent to blood vessels in the brains of moribund mice (A) but much fewer positive cells were observed in non-moribund (B) mice.
###end p 31
###begin p 32
###xml 206 207 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 279 280 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 288 289 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 533 534 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 561 562 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 565 566 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 574 575 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 578 579 576 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 608 610 606 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</italic>
###xml 603 610 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g006">Fig. <italic>6A</italic></xref>
###xml 665 666 663 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 730 731 728 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 770 772 768 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6B</italic>
###xml 765 772 763 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g006">Fig. <italic>6B</italic></xref>
###xml 809 810 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 837 838 835 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 871 872 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 902 904 900 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6C</italic>
###xml 897 904 895 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g006">Fig. <italic>6C</italic></xref>
###xml 951 952 949 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 960 961 958 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1067 1068 1065 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1072 1073 1070 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1094 1095 1090 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1099 1100 1095 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1159 1161 1153 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6D</italic>
###xml 1154 1161 1148 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g006">Fig. <italic>6D</italic></xref>
###xml 1311 1312 1305 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1334 1335 1328 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1354 1355 1348 1349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 1221 1225 <span type="species:ncbi:10090">mice</span>
We next performed flow cytometric analysis to determine the percentage of T cells accumulated in the brain vasculature that express OX40 during ECM in mice. In moribund mice, we find that 19.5+/-2.4% of CD3+ brain lymphocytes expressed OX40. Because OX40 is expressed on both CD4+ and CD8+ T cells and both subsets are known to play an active role in the pathogenesis of ECM, we next wanted to examine the distribution of OX40 among T cell subsets. During the symptomatic effector phase of ECM, we found that 13.68% and 84.34% of CD3+ brain lymphocytes were CD4+CD8- and CD4-CD8+ T cells, respectively (Fig. 6A). However, although there were comparatively fewer CD4+ T cells in the brains of mice with ECM, a majority of these CD4+ T cells (74.30%) expressed OX40 (Fig. 6B). Conversely, although 84.34% of CD3+ brain lymphocytes were CD8+ T cells, only 7.59% of these CD8+ T cells expressed OX40 (Fig. 6C). Consequently, although the proportion of CD4+ and CD8+ T cell subsets differed greatly in the brain during the effector phase of ECM, the absolute number of CD4+OX40+ (1184+/-250) and CD8+OX40+ (976+/-388) T cells remained approximately the same (Fig. 6D). We also measured the expression of OX40 in the spleen of mice with ECM and found that similar to the brain, OX40 was predominantly expressed on CD4+ T cells; 42.9% of CD4+ versus 3.9% of CD8+ splenic T cells expressed OX40 (data not shown).
###end p 32
###begin title 33
###xml 67 71 <span type="species:ncbi:10090">mice</span>
OX40 expression on T cell subsets present in the brain of moribund mice.
###end title 33
###begin p 34
###xml 160 162 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</italic>
###xml 166 167 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 175 176 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 176 178 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</italic>
###xml 183 184 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 187 188 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 193 195 190 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</italic>
###xml 200 201 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 205 206 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 249 251 246 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D:</italic>
###xml 300 301 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 356 357 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 407 408 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 411 412 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 421 422 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 425 426 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Total brain leukocytes (sequestered and nonsequestered) were stained with fluorescent-labeled antibodies against TCRbeta, CD4, CD8, and OX40. The proportion of A: CD4+ and CD8+B: OX40+CD4+ and C: OX40+ CD8+ T cells was determined by flow cytometry. D: Although OX40 is preferentially expressed on CD4+ T cells, due to the comparatively higher number of CD8+ T cells in the brain, the absolute number of OX40+CD4+ and OX40+CD8+ T cells accumulated in the brain vasculature is approximately the same.
###end p 34
###begin p 35
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 177 178 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 182 183 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 264 265 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 343 344 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
We also performed flow cytometric analysis of T cell subsets in infected C57BL/6 non-moribund mice. Results showed that non-moribund mice had fewer CD4+OX40+ (172+/-138) and CD8+OX40+ (55+/-44) T cells in the brain compared to moribund mice. This reduction in OX40+ brain lymphocytes is most likely a consequence of the significantly fewer CD3+ lymphocytes observed in the brain of non-moribund (1592+/-800) compared to moribund (13,072+/-3881) mice.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 349 362 349 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Wenisch1">[34]</xref>
###xml 741 745 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Oakley1">[11]</xref>
###xml 875 879 871 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 1021 1023 1017 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</italic>
###xml 1016 1023 1012 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g001">Fig. <italic>1A</italic></xref>
###xml 1132 1136 1128 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 1169 1171 1165 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1B</italic>
###xml 1164 1171 1160 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g001">Fig. <italic>1B</italic></xref>
###xml 1311 1315 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Togbe1">[40]</xref>
###xml 1428 1429 1424 1425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1429 1439 1425 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 1724 1729 1720 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1729 1733 1725 1729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Togbe1">[40]</xref>
###xml 1849 1854 1845 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1902 1906 1898 1902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Moore1">[41]</xref>
###xml 2075 2080 2071 2076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2227 2228 2223 2224 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 2229 2231 2225 2227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 2232 2233 2228 2229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2289 2293 2285 2289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 2461 2465 2457 2461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 2489 2494 2485 2490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2550 2554 2546 2550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 2786 2791 2782 2787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2917 2921 2913 2917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 3007 3011 3003 3007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
###xml 349 362 <span type="species:ncbi:5833">P. falciparum</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
###xml 1158 1162 <span type="species:ncbi:10090">mice</span>
###xml 1333 1337 <span type="species:ncbi:10090">mice</span>
###xml 1699 1703 <span type="species:ncbi:10090">mice</span>
###xml 1754 1758 <span type="species:ncbi:10090">mice</span>
###xml 1812 1816 <span type="species:ncbi:10090">mice</span>
###xml 2104 2108 <span type="species:ncbi:10090">mice</span>
###xml 2202 2206 <span type="species:ncbi:10090">mice</span>
###xml 2234 2238 <span type="species:ncbi:10090">mice</span>
###xml 2657 2661 <span type="species:ncbi:10090">mice</span>
###xml 2830 2834 <span type="species:ncbi:10090">mice</span>
###xml 2844 2848 <span type="species:ncbi:10090">mice</span>
Based on our microarray dataset, we chose to determine the in-depth role of three molecules in the pathogenesis of ECM in mice. First, our results demonstrate that the CD14 molecule plays a key role as a mediator of the pathogenesis of ECM. In earlier studies, the presence of elevated levels of soluble CD14 in serum from patients with complicated P. falciparum malaria has been reported [34]. Consistent with these findings, induction of CD14 transcription in brain tissue of susceptible mice exhibiting symptoms of ECM has recently been described by our group. In this microarray study, transcription of ECM was increased by 2.7+/-0.1 and 6.2+/-0.9 fold during ECM compared to BALB/c resistant and C57BL/6 non-moribund mice, respectively [11]. Further investigation in mice deficient for the CD14 gene revealed that loss of CD14 had a dual effect following infection with Pb-A parasites. First, CD14-deficient mice were highly resistant to ECM (only 21% of CD14-KO versus 80% of WT mice developed ECM, p<0.0004) (Fig. 1A) and secondly, loss of ECM associated with a significantly reduced parasite burden throughout the course of Pb-A infection in CD14-KO mice (Fig. 1B). Curiously, our data showing that loss of CD14 molecule associated with protection from ECM is somewhat in conflict with a previous study [40] in which 100% of mice deficient for the CD14 gene developed fatal ECM within 6 to 8 days after infection with 106P. berghei ANKA-parasitized RBCs. The reason behind the inconsistent findings as reported here and in the earlier study is not clear. However, we would like to emphasize that while our results are based on two independent ECM studies that involved a total of 19 CD14-KO mice, the study by Togbe et al[40] used only 7 CD14-KO mice in two independent experiments. Although the CD14-KO mice used in our study and the Togbe et al study were derived from the same genetic stock [41], it is possible that the CD14-KO strains used in the two studies differ in a subtle way that needs to be further examined. One such subtle difference is that the Togbe et al study utilized CD14-KO mice that were backcrossed at least ten times on the C57BL/6 genetic background while the CD14-KO mice used in our study (N7F14N1 mice) were backcrossed eight times. Differences in the Pb-A parasite lines could also account for the discrepant results between the two studies. Green fluorescent protein transgenic parasites derived from the cl15cy1 clone of Pb-A were used in the Togbe et al study while in this study, we used an uncloned line of Pb-A parasites that had undergone no genetic manipulation. Additional studies using a large sample size of mice will enhance our knowledge of the role of CD14 in ECM. Nonetheless, we have noted that in agreement with our results, Togbe et al also find that compared to WT C57BL/6 mice, CD14-KO mice had a more than two-fold reduction in parasite burden on day 7 post-Pb-A infection. In their study, parasite burden was not reported for the entire course of Pb-A infection.
###end p 37
###begin p 38
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Miyake1">[42]</xref>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-AkashiTakamura1">[43]</xref>
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Krishnegowda1">[44]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Parroche1">[45]</xref>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 370 373 370 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 401 404 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Coban1">[46]</xref>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 527 530 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 539 542 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Griffith1">[47]</xref>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 630 633 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 667 670 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 676 679 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 685 688 685 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 698 701 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Togbe1">[40]</xref>
###xml 774 779 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 861 864 861 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 903 907 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 918 922 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Lepenies1">[48]</xref>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
CD14 exerts it pro-inflammatory action by acting as an accessory molecule for TLRs [42], [43]. Recent studies have shown that malaria GPI and hemozoin are ligands for TLR2 and TLR9, respectively [44], [45]. However, studies investigating the role of TLR signaling pathways in the pathogenesis of ECM are conflicting. In a study conducted by Coban et al, TLR2-/- and TLR9-/- mice, but not TLR4-/-, TLR5-/-, and TLR7-/- mice, were significantly protected from ECM [46]. Griffith et al demonstrated that TLR9-/- mice, but not TLR2-/- and TLR4-/- mice, were partially protected from ECM [47]. In contrast, Togbe et al. found that TLR2-/- and TLR9-/- mice, as well as TLR3-/-, TLR4-/-, TLR6-/-, and TLR7-/- mice, were as sensitive to ECM as WT mice [40]. In agreement with Togbe et al, a study employing triple knockout mice found that the survival rates of TLR2/4/9-/- mice were comparable to WT mice after Pb-A infection [48]. While our study does not differentiate between the TLR-dependent and TLR-independent roles of CD14, on the whole the above considerations are not inconsistent with CD14 acting via the TLR signaling pathways in ECM.
###end p 38
###begin p 39
###xml 287 289 287 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1B</italic>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g001">Fig. <italic>1B</italic></xref>
###xml 456 458 456 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1C</italic>
###xml 451 458 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g001">Fig. <italic>1C</italic></xref>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 718 719 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 728 744 728 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 816 820 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Haziot1">[49]</xref>
###xml 850 857 850 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1013 1017 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Haziot2">[50]</xref>
###xml 1118 1126 1118 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1126 1130 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Kharazmi1">[51]</xref>
###xml 1131 1135 1131 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Trubowitz1">[53]</xref>
###xml 1236 1240 1236 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 1583 1587 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Haziot3">[54]</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 728 744 <span type="species:ncbi:562">Escherichia coli</span>
###xml 850 857 <span type="species:ncbi:562">E. coli</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1449 1454 <span type="species:ncbi:9606">human</span>
###xml 1551 1555 <span type="species:ncbi:10090">mice</span>
An unexpected result of this study was that loss of CD14 had an adverse effect on parasite growth in C57BL/6 mice. Mean parasite burden was approximately 2-fold lower (days 6 to 8 post-infection) and 3.6-fold lower (days 9 to 13 post-infection) in CD14-KO mice compared to WT mice (Fig. 1B). Importantly, resistance of CD14-KO mice to ECM was parasitemia dependent; the few CD14-KO mice that developed ECM had a parasite burden comparable to WT mice (Fig. 1C). Interestingly, this is not the first study to report the ability of CD14-deficient mice to control a pathogen burden more efficiently than WT mice. In a study conducted by Haziot et al, CD14-deficient mice were not only resistant to a lethal challenge (5x106 cfu) of Escherichia coli 0111:B4, but also had a 27-fold lower level of bacteremia in the blood [49]. This increased clearance of E. coli by CD14-deficient mice was attributed to a rapid infiltration of neutrophils (PMNs) in the peritoneal cavity that was significantly delayed in normal mice [50]. It is important to note that neutrophils have been shown to phagocytose and kill malaria parasites in vitro[51]-[53]. Nonetheless, further studies are needed to determine the mechanism of CD14 dependent regulation of Pb-A parasite density. Regardless of the mechanism, a therapeutic agent that targets CD14 could potentially be useful in preventing CM while simultaneously lowering parasite burden. Importantly, administration of human recombinant soluble CD14 (rsCD14) that might compete with CD14 receptor significantly protected mice from LPS-induced mortality [54].
###end p 39
###begin p 40
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 103 109 103 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g002">Fig. <italic>2</italic></xref>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 253 255 253 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3A</italic>
###xml 248 255 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g003">Fig. <italic>3A</italic></xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Kleshchenko1">[26]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-vandenBerg1">[27]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Bernardes1">[28]</xref>
###xml 636 644 636 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 653 664 653 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 735 743 735 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Pelletier1">[29]</xref>
###xml 970 978 970 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 987 998 987 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1178 1188 1178 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 636 644 <span type="species:ncbi:5664">L. major</span>
###xml 653 664 <span type="species:ncbi:5661">L. donovani</span>
###xml 735 743 <span type="species:ncbi:5664">L. major</span>
###xml 970 978 <span type="species:ncbi:5664">L. major</span>
###xml 987 998 <span type="species:ncbi:5661">L. donovani</span>
We have also demonstrated that galectin-3 protein is overexpressed in mice exhibiting symptoms of ECM (Fig. 2) and deletion of the galectin-3 gene confers partial but significant (p<0.0073) protection from ECM in C57BL/6 mice challenged with Pb-A (Fig. 3A). To our knowledge, this is the first study to address the role of galectin-3 in the pathogenesis of malaria. In previous studies, important and diverse roles have been assigned to galectin-3 during other protozoan parasite infections [26], [27], [28]. Interestingly, in a study evaluating the role of galectin-3 in leishmaniasis, galectin-3 recognized lipophosphoglycan (LPG) of L. major but not L. donovani and this species-specific recognition of the polygalactose epitope of L. major LPG resulted in cleavage of galectin-3 to a truncated form that is incapable of oligomerization, a prerequisite for the immunomodulatory activities of galectin-3 [29]. The authors proposed that truncation of galectin-3 during L. major but not L. donovani infection may account for differences in pathogenesis between the two species. A similar type of mechanism related to the processing of galectin-3 that is triggered by only a few Plasmodium species might be a reason why not all malaria parasites cause the pathogenesis of CM in their respective hosts.
###end p 40
###begin p 41
###xml 368 370 368 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4B</italic>
###xml 363 370 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g004">Fig. <italic>4B</italic></xref>
###xml 402 404 402 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4A</italic>
###xml 397 404 397 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g004">Fig. <italic>4A</italic></xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Liu1">[23]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-MacKinnon1">[55]</xref>
###xml 1498 1502 1498 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Hsu1">[56]</xref>
###xml 1578 1582 1578 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Seetharaman1">[57]</xref>
###xml 2072 2078 2072 2078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lgals3</italic>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 1036 1042 <span type="species:ncbi:9606">humans</span>
The above mentioned studies and our data provide evidence that galectin-3 can significantly alter the pathogenic course of a parasitic disease. In a majority of these infections, the role of galectin-3 appears to depend on direct interaction with the parasite. However our studies did not find any significant adherence of galectin-3 to schizont stage parasites (Fig. 4B) above background levels (Fig. 4A). We speculate that rather than binding parasite moieties, the role of galectin-3 in ECM might result from its binding endogenous oligosaccharides on matrix proteins. Galectin-3 is predominantly expressed in macrophages [23] and might be released upon lysis of brain-infiltrating macrophages. It has been observed that in galectin-3-KO mice, alternative macrophage activation induced by extracellular galectin-3 via IL-4/IL-13 is repressed [55], suggesting that this pathway might be involved in the role of ECM. In light of the results obtained in the leishmaniasis study, we systemically surveyed the galectin-3 gene for SNPs in humans using the HAPMAP data (). We discovered that this molecule contains one protein-coding SNP (rs4652, A/C) that shows a dramatic difference between sub-Saharan African and non-African populations (96% of chromosomes from the former show the C allele). This particular SNP maps to the N-terminal low-complexity region, which is unique to galectin-3 among members of the galectin family and is required for high avidity binding to multivalent glycoconjugates [56]. This low complexity segment is required for multimerization of galectin-3 [57] and is predicted to adopt a potentially collagen-like structure as a consequence of its repeating pattern of glycines and prolines. Given that the A/C SNP produces a P/T substitution, it could affect the multimerization of galectin-3. Hence, the difference between the sub-Saharan African and non-African populations at this protein position might be a reflection of selection driven by malaria which is prevalent in the former. Thus, despite the only partial level of protection from the lgals3 gene deletion, it might be useful to further investigate its role as a factor in CM pathogenesis.
###end p 41
###begin p 42
###xml 343 345 343 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5A</italic>
###xml 338 345 338 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g005">Fig. <italic>5A</italic></xref>
###xml 439 441 439 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5B</italic>
###xml 434 441 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g005">Fig. <italic>5B</italic></xref>
###xml 582 583 582 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Takasawa1">[58]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Baum1">[59]</xref>
###xml 827 828 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 835 836 835 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 912 913 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 940 941 940 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 949 950 949 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 979 981 979 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6A</italic>
###xml 974 981 974 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g006">Fig. <italic>6A</italic></xref>
###xml 1057 1058 1057 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1073 1075 1073 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6B</italic>
###xml 1068 1075 1068 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g006">Fig. <italic>6B</italic></xref>
###xml 1108 1109 1108 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1142 1144 1142 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6C</italic>
###xml 1137 1144 1137 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006793-g006">Fig. <italic>6C</italic></xref>
###xml 1183 1184 1183 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1235 1236 1235 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1239 1240 1239 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1249 1250 1249 1250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1253 1254 1253 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
We next chose to examine the costimulatory molecule OX40, a marker of both T cell activation and the generation of memory, during ECM. Histological examination of brain sections revealed that mice displaying symptoms of ECM strongly expressed OX40 on a subset of accumulating lymphoid cells in and adjacent to blood vessels in the brain (Fig. 5A). OX40 was expressed on comparatively fewer cells in brain tissue of non-moribund mice (Fig. 5B) suggesting that expression of OX40 in the brain may correlate with disease progression. Although OX40 is more commonly expressed on the CD4+ subset of T cells, expression has also been observed on CD8+ T cells that are strongly activated [58], [59]. We measured expression of OX40 on T cell subsets in the brain by flow cytometry in order to determine whether OX40 is expressed on CD4+ or CD8+ T lymphocytes. In mice exhibiting symptoms of ECM, 13.68% and 84.34% of CD3+ brain lymphocytes were CD4+ and CD8+ T cells, respectively (Fig. 6A). However, we found that OX40 was expressed in the majority (74.30%) of CD4+ T cells (Fig. 6B). In contrast, only 7.59% of CD8+ T cells co-expressed OX40 (Fig. 6C), but due to the greater number of CD8+ T cells in the brain, the absolute numbers of OX40+CD4+ and OX40+CD8+ T cells were similar.
###end p 42
###begin p 43
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 262 265 262 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Potter1">[6]</xref>
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 436 437 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 706 713 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 823 824 823 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
While it is difficult to assess the pathogenic nature of CD4+ T cells due to their early role in infection, the symptomatic effector phase of ECM is believed to be precipitated by perforin-mediated apoptosis of brain endothelial cells by pathogenic CD8+ T cells [6]. However, it is not known whether these pathogenic CD8+ T cells are a heterogeneous population with multiple phenotypes or a small homogeneous population such as the OX40+ subset of CD8+ T cells accumulated in the brain vasculature characterized in this study. Future studies performed in mice deficient for OX40 will need to be performed to determine whether OX40 is necessary for the pathogenesis of ECM. Furthermore, kinetic analysis by in vivo depletion of OX40 during different stages of Pb-A infection may be useful in determining which subset of OX40+ T cells could potentially be involved in disease.
###end p 43
###begin p 44
###xml 549 562 549 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 461 469 <span type="species:ncbi:9606">children</span>
###xml 549 562 <span type="species:ncbi:5833">P. falciparum</span>
We believe that by utilizing a combination of approaches including mining the dataset of transcriptionally altered genes that are specifically related to the pathogenesis of ECM and further investigations in gene knockout mice and immunohistology studies, we have identified three novel host molecules - CD14, galectin-3 and OX40 that may play a critical role in the pathogenesis of ECM. Further in depth studies in mice and comparative investigations of young children undergoing clinical symptoms of CM or experiencing asymptomatic malaria during P. falciparum infections will be required to firmly establish the role of these molecules in CM.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and parasite infections
###end title 46
###begin p 47
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
Six to eight week old female wild type (WT), CD14-KO (CD14-/-), galectin-3-KO (gal3-/-), and CD8-KO (CD8-/-) mice on the C57BL/6 background were purchased from The Jackson Laboratory (Bar Harbor, ME). CD14-KO and galectin-3-KO mice were incipient congenic mice backcrossed on the C57BL/6 genetic background eight and six generations, respectively. All mice in these studies were maintained at a National Institute of Allergy and Infectious Diseases or Food and Drug Administration animal care facility and treated in accordance and guidelines of the Animal Care and Use Committee.
###end p 47
###begin p 48
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. berghei</italic>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 372 373 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 0 10 <span type="species:ncbi:5821">P. berghei</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
P. berghei ANKA (Pb-A) parasites (an uncloned parasite line) were stored as frozen stabilities in liquid nitrogen at the Laboratory of Malaria and Vector Research, NIAID. Frozen stabilities were injected in donor mice that were compatible with the genetic background of the experimental mice. Subsequently, parasite infection was induced by intraperitoneal injection of 106Pb-A parasites and mice were monitored for clinical symptoms of ECM (hemi or paraplegia, deviation of the head, tendency to roll over upon stimulation, ataxia, and convulsions) beginning on day 3 post-infection. In most instances, parasitemia (parasitized RBCs/total RBCsx100) was enumerated by examining Giemsa-stained thin blood films.
###end p 48
###begin title 49
Statistical analysis
###end title 49
###begin p 50
###xml 111 115 <span type="species:ncbi:10090">mice</span>
The Fisher's exact test was used to determine differences in survival between WT and CD14-KO and galectin-3-KO mice. Differences in parasitemia were analyzed using two-way ANOVA or the Mann-Whitney test.
###end p 50
###begin title 51
Western blot analysis
###end title 51
###begin p 52
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 503 508 <span type="species:ncbi:9606">human</span>
To determine whether galectin-3 protein expression is associated with the ECM disease state, expression of galectin-3 protein was measured in whole brain tissue of moribund and non-moribund (infected C57BL/6), resistant (infected C57BL/6 CD8-KO), and normal (uninfected C57BL/6) mice. Brain samples were taken between days 6 and 10 post-infection. Protein samples from brain tissue were prepared as a 10% brain homogenate, and tissue specific galectin-3 protein was detected using antibody specific for human recombinant galectin-3 (Abcam Inc, Cambridge, MA) and a commercially obtained chemiluminescence-linked western blot kit (Western Light Tropix, Bedford, MA). Protein samples were subjected to electrophoresis on a 4-20% Tris-Glycine PAGE gel and then transferred onto a PVDF membrane. Following incubations with the primary and secondary antibodies, protein bands were visualized with ECL detection reagents, and the integrated optical densities (IOD) for each lane were measured using Meta Morph 6.1 Software.
###end p 52
###begin title 53
Immunohistological studies
###end title 53
###begin p 54
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 327 334 327 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnfrsf4</italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:9925">goat</span>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
###xml 369 375 <span type="species:ncbi:9986">rabbit</span>
###xml 381 385 <span type="species:ncbi:9925">goat</span>
Tissue sections were prepared from the brains of moribund and non-moribund mice infected with Pb-A for immunohistological staining of OX40. Brain samples were isolated from mice on day 6 post-infection. Tissue sections were fixed in formalin and then stained with a goat polyclonal antibody specific for recombinant mouse OX40/Tnfrsf4 (R&D Systems, Minneapolis, MN). A rabbit anti-goat antibody (Vector Laboratories, Burlingame, CA) was used for the next detection step by following the manufacture's instructions. Hematoxylin was used as the counterstain. Stained sections were examined by light microscopy.
###end p 54
###begin title 55
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
Binding of Pb-A parasites to galectin-3
###end title 55
###begin p 56
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pb-A</italic>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:9913">calf</span>
###xml 459 464 <span type="species:ncbi:10090">mouse</span>
###xml 503 508 <span type="species:ncbi:10090">mouse</span>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
###xml 842 846 <span type="species:ncbi:9925">goat</span>
###xml 898 904 <span type="species:ncbi:9793">donkey</span>
###xml 910 914 <span type="species:ncbi:9925">goat</span>
We investigated whether Pb-A infected red cells (IRBC) were able to bind directly to galectin-3. To accomplish this, whole blood was collected from mice infected with Pb-A at approximately 10% parasitemia. Parasites were cultured overnight in RPMI with 20% fetal calf serum to obtain schizont stage parasites. IRBC were then fixed in suspension, washed, and resuspended in PBS-0.1% BSA and fixed IRBC were treated with the following combinations: recombinant mouse galectin-3 (8 microg/ml), recombinant mouse galectin-3 (8 microg/ml) and lactose (20 mM), recombinant mouse galectin-3 and sucrose (20 mM), lactose (20 mM) alone, or sucrose (20 mM) alone. Samples were incubated for 1 h at 37degreesC, washed with PBS-0.1% BSA, fixed, and then resuspended in PBS-3% BSA. To detect the binding of galectin-3 to IRBC, samples were labeled with a goat anti-galectin-3 antibody followed by a fluorescent donkey anti-goat IgG. Images were collected on an epifluorescence microscope.
###end p 56
###begin title 57
###xml 49 54 <span type="species:ncbi:9606">human</span>
Single Nucleotide Polymorphism (SNP) analysis of human galectin-3
###end title 57
###begin p 58
###xml 537 541 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Wang1">[60]</xref>
To identify potentially relevant SNPs in the genes in this study, we surveyed the NCBI SNP database using the gene ids for the respective genes. All SNPs were collated and checked for significant differences between the 4 principle populations sampled in HAPMAP. The SNPS showing significant population-wise differences were then examined for evidence of changing the coding sequence of the protein or lying next to known transcription regulatory sites. The former set was also assessed for positive selection using data from Wang et al [60].
###end p 58
###begin title 59
Flow cytometry
###end title 59
###begin p 60
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Miu1">[61]</xref>
###xml 702 703 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 882 886 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006793-Kumar1">[62]</xref>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
We performed flow cytometry to determine the percentage of CD3+, CD4+, CD8+ lymphocytes and OX40 expressing lymphocytes in whole brain leukocyte and splenocyte populations taken from mice undergoing clinical symptoms of ECM on day 6 post-infection. Preparation of whole brain leukocytes from unperfused brain tissue was adapted with modifications from a method previously described [61]. Briefly, single cell suspensions of brain tissue were prepared by treatment with DNase-I (28 IU/ml; Sigma- Aldrich) and collagenase (0.5 mg/ml; Sigma- Aldrich) enzymes for 1 hr at 37degreesC under frequent agitation and trituration. Purification of leukocyte populations was accomplished by centrifugation at 1600xg for 20 min on 30% percoll (Sigma-Aldrich) and the gradient layer containing leukocytes was carefully removed. Splenocytes were prepared by using a previously described procedure [62].
###end p 60
###begin p 61
###xml 272 276 <span type="species:ncbi:9913">calf</span>
Single cell suspensions of brain leukocytes and splenocytes were blocked with anti-CD16-CD32 (BD Biosciences), stained with FITC-anti-TCRbeta, APC-anti-CD4, PerCP-anti-CD8, and PE-anti-OX40 (purchased from either BD Biosciences or eBiosciences) in PBS containing 2% fetal calf serum for 30 minutes at 4degreesC, washed three times, and then analysed on a FACSCalibur flow cytometer using CellQuest (BD Biosciences) and Flowjo (Treestar) software.
###end p 61
###begin p 62
###xml 135 139 <span type="species:ncbi:10090">mice</span>
We thank the veterinary staff at the Twinbrook III facility, NIAID and at Food and Drug Administration for the care and maintenance of mice. The views and opinions expressed here are those of the authors and should not be construed as the official opinion of the Food and Drug Administration.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis.
###end article-title 64
###begin article-title 65
###xml 11 19 <span type="species:ncbi:9606">children</span>
Caring for children with cerebral malaria: insights gleaned from 20 years on a research ward in Malawi.
###end article-title 65
###begin article-title 66
Cerebral malaria: the sequestration hypothesis.
###end article-title 66
###begin article-title 67
###xml 23 28 <span type="species:ncbi:9606">human</span>
The cytokine theory of human cerebral malaria.
###end article-title 67
###begin article-title 68
The pathogenesis of mammalian malaria.
###end article-title 68
###begin article-title 69
Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria.
###end article-title 69
###begin article-title 70
###xml 9 19 <span type="species:ncbi:5821">P. berghei</span>
###xml 99 108 <span type="species:ncbi:10090">nude mice</span>
Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice.
###end article-title 70
###begin article-title 71
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 61 67 <span type="species:ncbi:10090">murine</span>
L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.
###end article-title 71
###begin article-title 72
###xml 79 85 <span type="species:ncbi:10090">murine</span>
Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
###end article-title 72
###begin article-title 73
On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria.
###end article-title 73
###begin article-title 74
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Host biomarkers and biological pathways that are associated with the expression of experimental cerebral malaria in mice.
###end article-title 74
###begin article-title 75
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
###end article-title 75
###begin article-title 76
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CD14 mediates recognition and phagocytosis of apoptotic cells.
###end article-title 76
###begin article-title 77
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice.
###end article-title 77
###begin article-title 78
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 88 94 <span type="species:ncbi:10090">murine</span>
Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria.
###end article-title 78
###begin article-title 79
Galectins. Structure and function of a large family of animal lectins.
###end article-title 79
###begin article-title 80
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
###end article-title 80
###begin article-title 81
Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts.
###end article-title 81
###begin article-title 82
Secretion of the galectin family of mammalian carbohydrate-binding proteins.
###end article-title 82
###begin article-title 83
Galectins as inflammatory mediators.
###end article-title 83
###begin article-title 84
Galectin-3 in apoptosis, a novel therapeutic target.
###end article-title 84
###begin article-title 85
On the role of galectin-3 in cancer apoptosis.
###end article-title 85
###begin article-title 86
Regulatory roles of galectins in the immune response.
###end article-title 86
###begin article-title 87
Galectins as modulators of cell adhesion.
###end article-title 87
###begin article-title 88
Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.
###end article-title 88
###begin article-title 89
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 26 43 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells.
###end article-title 89
###begin article-title 90
LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition.
###end article-title 90
###begin article-title 91
###xml 0 17 <span type="species:ncbi:5811">Toxoplasma gondii</span>
Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity.
###end article-title 91
###begin article-title 92
###xml 51 67 <span type="species:ncbi:5664">Leishmania major</span>
Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope.
###end article-title 92
###begin article-title 93
Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes-a molecule related to nerve growth factor receptor.
###end article-title 93
###begin article-title 94
Roles of OX40 in the pathogenesis and the control of diseases.
###end article-title 94
###begin article-title 95
The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
###end article-title 95
###begin article-title 96
Regulation of CD4 T cell memory by OX40 (CD134).
###end article-title 96
###begin article-title 97
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 64 85 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria.
###end article-title 97
###begin article-title 98
Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.
###end article-title 98
###begin article-title 99
###xml 87 95 <span type="species:ncbi:9606">patients</span>
CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
###end article-title 99
###begin article-title 100
Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein.
###end article-title 100
###begin article-title 101
Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
###end article-title 101
###begin article-title 102
###xml 39 47 <span type="species:ncbi:9606">patients</span>
T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen.
###end article-title 102
###begin article-title 103
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine cerebral malaria development is independent of toll-like receptor signaling.
###end article-title 103
###begin article-title 104
###xml 57 63 <span type="species:ncbi:10090">murine</span>
Divergent response to LPS and bacteria in CD14-deficient murine macrophages.
###end article-title 104
###begin article-title 105
Roles for accessory molecules in microbial recognition by Toll-like receptors.
###end article-title 105
###begin article-title 106
TLR accessory molecules.
###end article-title 106
###begin article-title 107
###xml 94 115 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity.
###end article-title 107
###begin article-title 108
Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9.
###end article-title 108
###begin article-title 109
Pathological role of Toll-like receptor signaling in cerebral malaria.
###end article-title 109
###begin article-title 110
###xml 33 39 <span type="species:ncbi:10090">murine</span>
Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host.
###end article-title 110
###begin article-title 111
Induction of experimental cerebral malaria is independent of TLR2/4/9.
###end article-title 111
###begin article-title 112
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice.
###end article-title 112
###begin article-title 113
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice.
###end article-title 113
###begin article-title 114
###xml 90 111 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Polymorphonuclear leucocytes defective in oxidative metabolism inhibit in vitro growth of Plasmodium falciparum. Evidence against an oxygen-dependent mechanism.
###end article-title 114
###begin article-title 115
###xml 62 83 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 112 117 <span type="species:ncbi:9606">human</span>
Independence of complement on in vitro immune phagocytosis of Plasmodium falciparum parasitised erythrocytes by human monocytes and polymorphonuclear leukocytes.
###end article-title 115
###begin article-title 116
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasmodium falciparum: phagocytosis by polymorphonuclear leukocytes.
###end article-title 116
###begin article-title 117
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide).
###end article-title 117
###begin article-title 118
Regulation of alternative macrophage activation by galectin-3.
###end article-title 118
###begin article-title 119
###xml 48 53 <span type="species:ncbi:9606">human</span>
Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin.
###end article-title 119
###begin article-title 120
###xml 31 36 <span type="species:ncbi:9606">human</span>
X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution.
###end article-title 120
###begin article-title 121
###xml 45 50 <span type="species:ncbi:9606">human</span>
Expression of gp34 (OX40 ligand) and OX40 on human T cell clones.
###end article-title 121
###begin article-title 122
###xml 30 36 <span type="species:ncbi:10090">murine</span>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
###end article-title 122
###begin article-title 123
###xml 60 72 <span type="species:ncbi:9606">Homo sapiens</span>
Global landscape of recent inferred Darwinian selection for Homo sapiens.
###end article-title 123
###begin article-title 124
###xml 39 45 <span type="species:ncbi:10090">murine</span>
Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency.
###end article-title 124
###begin article-title 125
###xml 67 93 <span type="species:ncbi:54757">Plasmodium vinckei vinckei</span>
Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development.
###end article-title 125
###begin p 126
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 126
###begin p 127
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Only NIH intramural and FDA intramural funding was used to conduct this study. No outside funding sources were used at any time for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 127

